Athymic mice were treated with recombinant parathyroid hormone (PTH), a well-known stimulator of bone turnover, inoculated mice with prostate cancer cells, and found that mice treated with PTH had increased bone formation adjacent to tumor regions compared to control mice [145]. Here, PTH is linked to neoplasm.